Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L15 pseudogene 12 (RPL15P12) is a noncoding pseudogene related to the ribosomal protein L15 (RPL15) gene[2][3]. Pseudogenes typically arise from duplication or processing of a functional gene but lack the capability to produce functional proteins due to disabling mutations or loss of regulatory sequences, such as promoters[8]. RPL15P12 does not encode a functional ribosomal protein, has no known biological activity, and is not implicated as a therapeutic target. Information concerning function, disease roles, drug interactions, or biomarker usage pertains to the parent RPL15 gene, not this pseudogene[3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L15 pseudogene 12 (RPL15P12).